Chicago Booth logo

The University of Chicago Booth School of Business

Skip navigation
University of Chicago Booth School of Business
AboutContactVisitGSB Home

Alumni Sharing Series: Jun Bao, '99

May 23, 2018: 7:00 PM - 9:00 PM

You are cordially invited to a dinner with distinguished alum Dr. Jun Bao, '99 to discuss trends and future directions in the biotech industry.

Learn more.


To be confirmed with attendees
Hong Kong, Hong Kong


HK$500 per person (dinner included)


Register Online
Deadline: 5/23/2018


Yiwei Jiang, '15
5592 6606

Event Details

Dr. Bao has over 20 years of experience in business development and scientific research. He will share valuable insights in biotech investment and valuation with a focus on immuno-oncology. Thanks to the latest changes in the HKEX listing rules we will see much stronger interests in biotech investment in Hong Kong and this is an event you should not miss.

Speaker Biography
Dr. Jun Bao is Senior Vice President and Chief Business Officer of Shenogen Pharma Group. He also serves as a member of board of directors as well as acting Chief Financial Officer. He is responsible for company's business development, financing and corporate strategy. He has over 20 years of combined business and science experiences. He is well-experienced in the areas of new drug R&D, technology transfer, licensing and business development, venture investment and corporate financing. Before he joined Shenogen, Dr. Bao was Director, Worldwide Business Development, Head of China at GlaxoSmithKline (GSK), responsible for business development activities in China. Prior to GSK, he worked at Onyx Pharmaceuticals, ICOS Corporation and Cell Therapeutics as a business development executive with progressive responsibilities. Dr. Bao also worked as a finance manager in Procter & Gamble based in Cincinnati. He received a BS in Microbiology from Shandong University and a PhD in Neuroscience from University of Kansas. Dr. Bao completed his postdoctoral fellowship in Johns Hopkins University. In addition, he received an MBA in Finance from University of Chicago. He has authored/co-authored more than 30 research publications and co-founded two start-up biotech companies. Dr. Bao was also a board member of BayHelix.


Give Online

The safest investment you'll make this year